Roundtable on Black in cancer research and oncology - presented by Dr. Brandon Blue MD and Dr. Kilan Ashad-Bishop and Drs. Onyinye and Folu Balogun and Runcie C.W. Chidebe Dip., BSc., MSc., and Kathryn Mcginnis and Dr Paraskevi Mallini and Dr. Lisa Hoffmann-Haas

Roundtable on Black in cancer research and oncology

Brandon Blue, Kilan Ashad-Bishop, Onyinye and Folu Balogun and Runcie C.W. Chidebe

Dr. Brandon Blue MDDr. Kilan Ashad-BishopDrs. Onyinye and Folu BalogunRuncie C.W. Chidebe Dip., BSc., MSc.,
Slide at 45:11
Call to Action There is an unequal distribution of oncology clinical trials (CT) and access to cancer treatment globally. Many ABC patients in Low-and-middle-income countries (LMICs) do not benefit from CT and also face the huge challenge of access to essential medicines. Africa has only 109 open oncology clinical trials1. Odedina, et al., , (2020)
1
References
  • 1.
    F. T. Odedina and O. Ginsburg (2020) Oncology Clinical Trials in Africa: Emerging and Operational Issues. JCO Global Oncology
Share slide
Summary (AI generated)

Globally, many metastatic breast cancer patients in low and middle-income countries face the significant challenge of not having access to clinical trials and essential medicines. A striking example of this issue can be seen in Africa, where there are currently only a few, if any, open oncology clinical trials available throughout the entire continent.